Back to search

Article

Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer

2020-12-15

Abstract excerpt

<h4>Background: </h4> KRAS is the most frequently mutated oncogene in cancer, however efforts to develop targeted therapies have been largely unsuccessful. Recently, two small-molecule inhibitors, AMG 510 and MRTX849, have shown promising activity in KRAS G12C-mutant solid tumors. The current study aims to assess the molecular profile of KRAS G12C in colorectal (CRC) and non-small-cell lung cancer (NSCLC) tested i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1e5664ee-fc3c-5224-bdc2-725212c22d4e
DOI
10.21203/rs.3.rs-108171/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancerDOI 10.21203/rs.3.rs-108171/v1
Select a neighboring publication to make it the new centre.